Literature DB >> 26837375

Cerebral palsy.

Neil Wimalasundera1, Valerie L Stevenson2.   

Abstract

Cerebral palsy has always been known as a disorder of movement and posture resulting from a non-progressive injury to the developing brain; however, more recent definitions allow clinicians to appreciate more than just the movement disorder. Accurate classification of cerebral palsy into distribution, motor type and functional level has advanced research. It also facilitates appropriate targeting of interventions to functional level and more accurate prognosis prediction. The prevalence of cerebral palsy remains fairly static at 2-3 per 1000 live births but there have been some changes in trends for specific causal groups. Interventions for cerebral palsy have historically been medical and physically focused, often with limited evidence to support their efficacy. The use of more appropriate outcome measures encompassing quality of life and participation is helping to deliver treatments which are more meaningful for people with cerebral palsy and their carers. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  CEREBRAL PALSY; DYSTONIA; INTRATHECAL BACLOFEN; SPASTICITY

Mesh:

Year:  2016        PMID: 26837375     DOI: 10.1136/practneurol-2015-001184

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  23 in total

1.  Variants of the OLIG2 Gene are Associated with Cerebral Palsy in Chinese Han Infants with Hypoxic-Ischemic Encephalopathy.

Authors:  Liya Sun; Lei Xia; Mingtai Wang; Dengna Zhu; Yangong Wang; Dan Bi; Juan Song; Caiyun Ma; Chao Gao; Xiaoli Zhang; Yanyan Sun; Xiaoyang Wang; Changlian Zhu; Qinghe Xing
Journal:  Neuromolecular Med       Date:  2018-09-03       Impact factor: 3.843

Review 2.  Anaesthesia and cerebral palsy.

Authors:  H Hayakawa; E S Pincott; U Ali
Journal:  BJA Educ       Date:  2021-11-15

3.  Downregulation of transcription factor TCTP elevates microRNA-200a expression to restrain Myt1L expression, thereby improving neurobehavior and oxidative stress injury in cerebral palsy rats.

Authors:  Xiaoxia He; Zibo Liu; Yatao Pang; Wei Xu; Long Zhao; Hongling Li
Journal:  Cell Cycle       Date:  2020-03-15       Impact factor: 4.534

4.  Elevated fracture risk for adults with neurodevelopmental disabilities.

Authors:  Daniel G Whitney; Michelle S Caird; Karl J Jepsen; Neil S Kamdar; Christina N Marsack-Topolewski; Edward A Hurvitz; Mark D Peterson
Journal:  Bone       Date:  2019-10-24       Impact factor: 4.398

5.  Ataxic-hypotonic cerebral palsy in a cerebral palsy registry: Insights into a distinct subtype.

Authors:  Jake P Levy; Maryam Oskoui; Pamela Ng; John Andersen; David Buckley; Darcy Fehlings; Adam Kirton; Louise Koclas; Nicole Pigeon; Esias van Rensburg; Ellen Wood; Michael Shevell
Journal:  Neurol Clin Pract       Date:  2020-04

6.  Using the PODCI to Measure Motor Function and Parent Expectations in Children With Cerebral Palsy.

Authors:  Kimberley S Scott; Gardenia O Barbosa; Jeff Pan; Jill C Heathcock
Journal:  Phys Ther       Date:  2021-12-01

7.  Disrupted Bone Metabolism in Long-Term Bedridden Patients.

Authors:  Keiko Eimori; Naoto Endo; Seiji Uchiyama; Yoshinori Takahashi; Hiroyuki Kawashima; Kei Watanabe
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

8.  A child with a novel DDX3X variant mimicking cerebral palsy: a case report.

Authors:  Liqin Hu; Xiaoqin Xin; Shaobin Lin; Min Luo; Junkun Chen; Hongsheng Qiu; Li Ma; Jungao Huang
Journal:  Ital J Pediatr       Date:  2020-06-29       Impact factor: 2.638

9.  Metabolomic Profiling of Cerebral Palsy Brain Tissue Reveals Novel Central Biomarkers and Biochemical Pathways Associated with the Disease: A Pilot Study.

Authors:  Zeynep Alpay Savasan; Ali Yilmaz; Zafer Ugur; Buket Aydas; Ray O Bahado-Singh; Stewart F Graham
Journal:  Metabolites       Date:  2019-02-02

10.  Induction of regional chemokine expression in response to human umbilical cord blood cell infusion in the neonatal mouse ischemia-reperfusion brain injury model.

Authors:  Nobuyasu Baba; Feifei Wang; Michiro Iizuka; Yuan Shen; Tatsuyuki Yamashita; Kimiko Takaishi; Emi Tsuru; Sachio Matsushima; Mitsuhiko Miyamura; Mikiya Fujieda; Masayuki Tsuda; Yusuke Sagara; Nagamasa Maeda
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.